Carrying extra weight is a real cause for concern. Overweight
and obesity are risk factors for a number of diseases,
including Type 2 diabetes (diabetes mellitus), high cholesterol,
hypertension, osteoarthritis, obesity-related
cardiomyopathy and perhaps even some forms of cancer (breast,
colorectal, endometrial and kidney)1.
Although successful, long-term weight loss still requires
a commitment to modifying lifestyle behaviors, there may
be more you can do to empower healthy weight loss.
Unlike other types of bariatric surgery (laparoscopic
banding or gastric
bypass,) that alter the stomach’s anatomy,
VBLOC Therapy is delivered by an implantable, investigational
device intended to block signals carried on the vagus nerve
between the brain and the digestive system that control
sensations of hunger, satisfaction and fullness.
The device
itself uses laparoscopically-implanted electrodes that
deliver high-frequency, low-energy electrical impulses
to block the signals conveyed through the vagal nerves.
By being able to reversibly control these signals, VBLOC
Therapy may aid in weight loss.
VBLOC Therapy includes both external and implanted components.
VBLOC Therapy may be turned off and is designed to be reversible,
programmable and non-invasively adjustable.
The EMPOWER clinical research study is now enrolling patients
to evaluate the safety and effectiveness of the investigational
device that delivers VBLOC Therapy.
For more information about VBLOC Therapy and the EMPOWER
clinical research study, please call the nurse-staffed
information line at 1-866-291-9146 Monday–Thursday,
7 a.m.–7 p.m.
and Friday, 7 a.m.–6 p.m., CST.
CAUTION: Investigational device. Limited by Federal law
to investigational use.
